Loading stock data…
QTRX
$2.77-0.11 (-3.82%)
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Quanterix Corporation in the Healthcare sector is trading at $2.77. Wall Street consensus targets $5.33 (3 analysts), implying a +92.5% move over the next 12 months. The stock is currently near its 52-week low of $2.56, remaining 48.5% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +92.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Sector + growth-aware fair-multiple estimate. Fair P/E = sector-anchor + (ROE × 25) + (max(revenue growth, earnings growth) × 30), capped at 1.6× sector. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. The sector anchor (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) keeps quality compounders from being mechanically penalized against utility multiples. Result is a normalised multiple gauge — not a price target.
Current Price$2.77
Potential Downside
0%
Whystock Fair Value$2.77
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus3 analysts
Hold
Mean target$5.33+92.5%
Range$4.00 – $7.00
Fundamentals
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Si...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$153.02M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.32
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-36.23%
Volume
Today's trading volume
1.56M
Recent News
Quanterix (QTRX) Q1 2026 Earnings Transcript
Need a quote from a Motley Fool analyst? Joshua Young: Thank you, Preyila, and good afternoon, everybody. With me on today's call are Everett Cunningham, Quanterix' President and CEO; and Vandana Sriram, Quanterix' Chief Financial Officer.
Quanterix Q1 Earnings Call Highlights
Quanterix (NASDAQ:QTRX) reported first-quarter 2026 revenue of $36.4 million, up 20% year-over-year, as leadership outlined operational and commercial changes aimed at improving execution in a challenging end-market backdrop. The company also highlighted stepped-up investment in its Alzheimer’s diag
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates
Quanterix (QTRX) delivered earnings and revenue surprises of -25.81% and -0.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
How The Quanterix (QTRX) Story Is Shifting After The Latest Fair Value Reset
Quanterix is back in focus after analysts reset their fair value estimate from US$7.33 to US$5.33, a cut of about 27% that reframes what they see as a central case for the stock. The latest research links this move directly to a refreshed view of execution risk, with bulls and bears splitting over whether the lower target adds caution or signals deeper concern. As you read on, you will see how these shifting price targets can help you track the evolving story around Quanterix. Analyst Price...
Quanterix (QTRX) Q4 2025 Earnings Call Transcript
Need a quote from a Motley Fool analyst? With me on today's call are Everett Cunningham, Quanterix Corporation President and CEO, and Vandana Sriram, Quanterix Corporation Chief Financial Officer. During the course of today's presentation, we will make forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act.